NCT00662740View on ClinicalTrials.gov

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3TerminatedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

April 15, 2008

Primary Completion Date

November 21, 2008

Study Completion Date

November 21, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium/Salmeterol QD

Tiotropium/Salmeterol Inhalation Powder, Hard Polyethylene Capsule

DRUG

Placebo

Placebo Inhalation Powder, hard PE capsule / hard gelatine capsule

DRUG

Salmeterol

Salmeterol Inhalation Powder, hard PE capsule

DRUG

Tiotropium/Salmeterol QD+ Salmeterol

Tiotropium/Salmeterol Inhalation Powder, Hard Polyethylene Capsule, plus Salmeterol Inhalation Powder, hard PE capsule

DRUG

Tiotropium (Spiriva®)

Tiotropium, Spiriva®

Trial Locations (72)

Unknown

1184.14.01013 Boehringer Ingelheim Investigational Site, Boulder

1184.14.01018 Boehringer Ingelheim Investigational Site, Wheat Ridge

1184.14.01006 Boehringer Ingelheim Investigational Site, Winter Park

1184.14.01003 Boehringer Ingelheim Investigational Site, Coeur d'Alene

1184.14.01015 Boehringer Ingelheim Investigational Site, South Bend

1184.14.01007 Boehringer Ingelheim Investigational Site, Lafayette

1184.14.01005 Boehringer Ingelheim Investigational Site, Bangor

1184.14.01020 Boehringer Ingelheim Investigational Site, Edina

1184.14.01009 Boehringer Ingelheim Investigational Site, Burlington

1184.14.01002 Boehringer Ingelheim Investigational Site, Cincinnati

1184.14.01021 Boehringer Ingelheim Investigational Site, Toledo

1184.14.01012 Boehringer Ingelheim Investigational Site, East Providence

1184.14.01017 Boehringer Ingelheim Investigational Site, Greenville

1184.14.01008 Boehringer Ingelheim Investigational Site, Spartanburg

1184.14.01014 Boehringer Ingelheim Investigational Site, Houston

1184.14.01022 Boehringer Ingelheim Investigational Site, Killeen

1184.14.01001 Boehringer Ingelheim Investigational Site, San Antonio

1184.14.01010 Boehringer Ingelheim Investigational Site, Temple

1184.14.01011 Boehringer Ingelheim Investigational Site, Richmond

1184.14.01019 Boehringer Ingelheim Investigational Site, Richmond

1184.14.43001 Boehringer Ingelheim Investigational Site, Feldbach

1184.14.32001 Boehringer Ingelheim Investigational Site, Brussels

1184.14.32004 Boehringer Ingelheim Investigational Site, Turnhout

1184.14.02005 Boehringer Ingelheim Investigational Site, Calgary

1184.14.02003 Boehringer Ingelheim Investigational Site, Chilliwack

1184.14.02010 Boehringer Ingelheim Investigational Site, Vancouver

1184.14.02001 Boehringer Ingelheim Investigational Site, Niagara Falls

1184.14.02002 Boehringer Ingelheim Investigational Site, La Malbaie

1184.14.02008 Boehringer Ingelheim Investigational Site, Ste-Foy

1184.14.02007 Boehringer Ingelheim Investigational Site, Saskatoon

1184.14.45001 Boehringer Ingelheim Investigational Site, Hvidovre

1184.14.45002 Boehringer Ingelheim Investigational Site, København NV

1184.14.37202 Boehringer Ingelheim Investigational Site, Tallinn

1184.14.37201 Boehringer Ingelheim Investigational Site, Tartu

1184.14.35802 Boehringer Ingelheim Investigational Site, Espoo

1184.14.35801 Boehringer Ingelheim Investigational Site, HUS

1184.14.3301A Boehringer Ingelheim Investigational Site, Brest

1184.14.3304A Boehringer Ingelheim Investigational Site, Marseille

1184.14.3302A Boehringer Ingelheim Investigational Site, Montpellier

1184.14.3303A Boehringer Ingelheim Investigational Site, Perpignan

1184.14.3303B Boehringer Ingelheim Investigational Site, Perpignan

1184.14.3303C Boehringer Ingelheim Investigational Site, Perpignan

1184.14.49003 Boehringer Ingelheim Investigational Site, Berlin

1184.14.49004 Boehringer Ingelheim Investigational Site, Berlin

1184.14.49006 Boehringer Ingelheim Investigational Site, Berlin

1184.14.49008 Boehringer Ingelheim Investigational Site, Berlin

1184.14.49002 Boehringer Ingelheim Investigational Site, Hamburg

1184.14.49007 Boehringer Ingelheim Investigational Site, Hamburg

1184.14.49001 Boehringer Ingelheim Investigational Site, Leipzig

1184.14.30001 Boehringer Ingelheim Investigational Site, Athens

1184.14.30004 Boehringer Ingelheim Investigational Site, Nafplion

1184.14.30006 Boehringer Ingelheim Investigational Site, Rethymno

1184.14.36002 Boehringer Ingelheim Investigational Site, Debrecen

1184.14.36001 Boehringer Ingelheim Investigational Site, Hodmezövasarhely

1184.14.36005 Boehringer Ingelheim Investigational Site, Komló

1184.14.36004 Boehringer Ingelheim Investigational Site, Miskolc

1184.14.39001 Boehringer Ingelheim Investigational Site, Pisa

1184.14.37101 Boehringer Ingelheim Investigational Site, Krāslava

1184.14.37103 Boehringer Ingelheim Investigational Site, Kuldīga

1184.14.37102 Boehringer Ingelheim Investigational Site, Talsi

1184.14.37003 Boehringer Ingelheim Investigational Site, Klaipėda

1184.14.31004 Boehringer Ingelheim Investigational Site, Eindhoven

1184.14.31003 Boehringer Ingelheim Investigational Site, Heerlen

1184.14.31002 Boehringer Ingelheim Investigational Site, Nieuwegein

1184.14.31001 Boehringer Ingelheim Investigational Site, Veldhoven

1184.14.42103 Boehringer Ingelheim Investigational Site, Bardejov

1184.14.82001 Boehringer Ingelheim Investigational Site, Seoul

1184.14.82002 Boehringer Ingelheim Investigational Site, Seoul

1184.14.82003 Boehringer Ingelheim Investigational Site, Seoul

1184.14.46002 Boehringer Ingelheim Investigational Site, Linköping

1184.14.46001 Boehringer Ingelheim Investigational Site, Lund

1184.14.46003 Boehringer Ingelheim Investigational Site, Sundsvall

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY